Saxena Nishant C
Transaction: 08/11/2026
BUY
Change
+2,600
Price
$9.63
Filing
08/12/2026
Type
BUY
Corbus Pharmaceuticals Holdings, Inc.
CRBP • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$180.83M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 8.07Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:51 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$180.83M
52W Range7.12 - 20.56
Beta2.56
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio8.07
Quick Ratio8.07
Target$33.00
Price$0.00
Change0.00%
Market Cap$180.83M
52W Range7.12 - 20.56
Beta2.56
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio8.07
Quick Ratio8.07
Target$33.00
Target Median$33.00
Target Range33.00 - 33.00
Volume541.70K
Avg Volume421.28K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 8.07Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$33.00
Mean
$33.00
Median
$33.00
High
$33.00
Insider Transactions
Recent executive and insider activity
Moran Sean F.
Transaction: 08/07/2026
SELL
Change
-12,000
Price
$10.08
Filing
08/10/2026
Type
SELL
Cohen Yuval
Transaction: 08/07/2026
SELL
Change
-17,000
Price
$10.08
Filing
08/10/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Saxena Nishant C | BUY | +2,600 | $9.63 | 08/11/2026 | 08/12/2026 |
| Moran Sean F. | SELL | -12,000 | $10.08 | 08/07/2026 | 08/10/2026 |
| Cohen Yuval | SELL | -17,000 | $10.08 | 08/07/2026 | 08/10/2026 |
| Nicacio Leonardo Viana | OTHER | 0 | Not reported | 08/03/2026 | 08/04/2026 |
| Jenkins John Kenneth | SELL | -4,800 | $7.91 | 06/10/2026 | 06/11/2026 |
| Altmeyer Anne | SELL | -2,412 | $7.91 | 06/10/2026 | 06/11/2026 |
| Kung Winston | SELL | -2,026 | $7.91 | 06/10/2026 | 06/11/2026 |
| Saxena Nishant C | BUY | +9,000 | $7.58 | 06/03/2026 | 06/03/2026 |
| Saxena Nishant C | BUY | +4,500 | $7.33 | 06/02/2026 | 06/03/2026 |
| Saxena Nishant C | OTHER | 0 | Not reported | 05/21/2026 | 05/22/2026 |
| Saxena Nishant C | BUY | +192,300 | $11.51 | 05/21/2026 | 05/22/2026 |
| Pfeiffenberger Brent | BUY | +7,500 | Not reported | 05/19/2026 | 05/21/2026 |
| Pfeiffenberger Brent | BUY | +24,700 | $9.15 | 05/19/2026 | 05/21/2026 |
| Ben Yong | BUY | +3,800 | Not reported | 05/19/2026 | 05/21/2026 |
| Ben Yong | BUY | +12,300 | $9.15 | 05/19/2026 | 05/21/2026 |
| Altmeyer Anne | BUY | +3,800 | Not reported | 05/19/2026 | 05/21/2026 |
| Altmeyer Anne | BUY | +12,300 | $9.15 | 05/19/2026 | 05/21/2026 |
| Jenkins John Kenneth | BUY | +3,800 | Not reported | 05/19/2026 | 05/21/2026 |
| Jenkins John Kenneth | BUY | +12,300 | $9.15 | 05/19/2026 | 05/21/2026 |
| Jacques Rachelle Suzanne | BUY | +3,800 | Not reported | 05/19/2026 | 05/21/2026 |